BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37603354)

  • 1. Adjuvant Chemotherapy Improves Survival for Children With Massive Choroidal Invasion of Retinoblastoma.
    Feng ZX; Zhao J; Zhang N; Jin M; Gallie B
    Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):27. PubMed ID: 37603354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
    Chévez-Barrios P; Eagle RC; Krailo M; Piao J; Albert DM; Gao Y; Vemuganti G; Ali MJ; Khetan V; Honavar SG; O'Brien J; Leahey AM; Matthay K; Meadows A; Chintagumpala M
    J Clin Oncol; 2019 Nov; 37(31):2883-2891. PubMed ID: 31539297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
    Aerts I; Sastre-Garau X; Savignoni A; Lumbroso-Le Rouic L; Thebaud-Leculée E; Frappaz D; Coze C; Thomas C; Gauthier-Villars M; Lévy-Gabriel C; Brisse HJ; Desjardins L; Doz F
    J Clin Oncol; 2013 Apr; 31(11):1458-63. PubMed ID: 23460706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
    Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
    Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
    J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?
    Chantada GL; Dunkel IJ; de Dávila MT; Abramson DH
    Br J Ophthalmol; 2004 Aug; 88(8):1069-73. PubMed ID: 15258027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of high risk pathological features between primary and secondary enucleation for retinoblastoma.
    Mohammad M; Shehada R; Al-Nawaiseh I; Mehyar M; AlHussaini M; Jaradat I; Sultan I; Halalsheh H; Khzouz J; Yousef YA
    Eur J Ophthalmol; 2023 Sep; 33(5):2014-2023. PubMed ID: 36760120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC).
    Alkatan HM; AlQahtani FS; Maktabi AM
    Int Ophthalmol; 2020 Jul; 40(7):1739-1747. PubMed ID: 32193778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of children with retinoblastoma and isolated choroidal invasion.
    Bosaleh A; Sampor C; Solernou V; Fandiño A; Domínguez J; de Dávila MT; Chantada GL
    Arch Ophthalmol; 2012 Jun; 130(6):724-9. PubMed ID: 22801832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma.
    Zhao J; Feng ZX; Wei M; Liu G; Solarte CE; Li B; Wang Y; Zhang C; Gallie BL
    Ophthalmol Retina; 2020 Jun; 4(6):630-639. PubMed ID: 32387053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
    Pérez V; Sampor C; Rey G; Parareda-Salles A; Kopp K; Dabezies AP; Dufort G; Zelter M; López JP; Urbieta M; Alcalde-Ruiz E; Catala-Mora J; Suñol M; Ossandon D; Fandiño AC; Croxatto JO; de Dávila MTG; Reaman G; Ravindranath Y; Chantada GL
    JAMA Ophthalmol; 2018 Jul; 136(7):747-752. PubMed ID: 29799944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
    Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
    Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
    Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
    Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk features in primary versus secondary enucleated globes with advanced retinoblastoma: a retrospective histopathological study.
    Alkatan HM; Al-Dahmash SA; Almesfer SA; AlQahtani FS; Maktabi AMY
    Int Ophthalmol; 2020 Nov; 40(11):2875-2887. PubMed ID: 32632618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postenucleation adjuvant therapy in high-risk retinoblastoma.
    Honavar SG; Singh AD; Shields CL; Meadows AT; Demirci H; Cater J; Shields JA
    Arch Ophthalmol; 2002 Jul; 120(7):923-31. PubMed ID: 12096963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome.
    Cuenca A; Giron F; Castro D; Fandiño A; Guitter M; de Dávila MT; Chantada G
    Arch Ophthalmol; 2009 Aug; 127(8):1006-10. PubMed ID: 19667337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study.
    Kaliki S; Srinivasan V; Gupta A; Mishra DK; Naik MN
    Ophthalmology; 2015 Jun; 122(6):1165-72. PubMed ID: 25841975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma.
    Mustafa MM; Jamshed A; Khafaga Y; Mourad WA; Al-Mesfer S; Kofide A; El-Husseiny G; Gray A
    J Pediatr Hematol Oncol; 1999; 21(5):364-9. PubMed ID: 10524448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging for tumor restaging after chemotherapy in retinoblastoma with optic nerve invasion.
    Chawla B; Chaurasia S; Sharma S; Pattebahadur R; Hasan F; Seth R; Kashyap S; Sen S
    Ophthalmic Genet; 2018 Oct; 39(5):584-588. PubMed ID: 30089224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.